51 related articles for article (PubMed ID: 9638591)
1. Involvement of AMPA receptors in posterior locomotor activity in the rabbit: an in vivo study.
Bonnot A; Corio M; Bouc AM; Viala D
J Physiol Paris; 1998 Feb; 92(1):5-15. PubMed ID: 9638591
[TBL] [Abstract][Full Text] [Related]
2. Role of AMPA receptor desensitization and the side effects of a DMSO vehicle on reticulospinal EPSPs and locomotor activity.
Tsvyetlynska NA; Hill RH; Grillner S
J Neurophysiol; 2005 Dec; 94(6):3951-60. PubMed ID: 16107533
[TBL] [Abstract][Full Text] [Related]
3. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors mediate development, but not maintenance, of secondary allodynia evoked by first-degree burn in the rat.
Jones TL; Sorkin LS
J Pharmacol Exp Ther; 2004 Jul; 310(1):223-9. PubMed ID: 15007101
[TBL] [Abstract][Full Text] [Related]
4. New role for spinal Stargazin in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated pain sensitization after inflammation.
Tao F; Skinner J; Su Q; Johns RA
J Neurosci Res; 2006 Sep; 84(4):867-73. PubMed ID: 16791853
[TBL] [Abstract][Full Text] [Related]
5. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
6. AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo.
Corona JC; Tapia R
J Neurochem; 2004 May; 89(4):988-97. PubMed ID: 15140197
[TBL] [Abstract][Full Text] [Related]
7. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
8. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
Stephens DN; Brown G
Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
[TBL] [Abstract][Full Text] [Related]
9. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
Mead AN; Stephens DN
J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological characterisations of rat lamina I dorsal horn neurones and the involvement of excitatory amino acid receptors.
Seagrove LC; Suzuki R; Dickenson AH
Pain; 2004 Mar; 108(1-2):76-87. PubMed ID: 15109510
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
[TBL] [Abstract][Full Text] [Related]
12. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
[TBL] [Abstract][Full Text] [Related]
13. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
14. Effects of intrathecal glutamatergic drugs on locomotion I. NMDA in short-term spinal cats.
Chau C; Giroux N; Barbeau H; Jordan L; Rossignol S
J Neurophysiol; 2002 Dec; 88(6):3032-45. PubMed ID: 12466428
[TBL] [Abstract][Full Text] [Related]
15. Effects of intrathecal glutamatergic drugs on locomotion. II. NMDA and AP-5 in intact and late spinal cats.
Giroux N; Chau C; Barbeau H; Reader TA; Rossignol S
J Neurophysiol; 2003 Aug; 90(2):1027-45. PubMed ID: 12904502
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of AMPA-type glutamate receptor antagonists on intermale social behavior in two mouse lines bidirectionally selected for offensive aggression.
Vekovischeva OY; Aitta-aho T; Verbitskaya E; Sandnabba K; Korpi ER
Pharmacol Biochem Behav; 2007; 87(2):241-9. PubMed ID: 17537494
[TBL] [Abstract][Full Text] [Related]
17. AMPA receptor activation reduces epileptiform activity in the rat neocortex.
Addae JI; Ali N; Youssef FF; Stone TW
Brain Res; 2007 Jul; 1158():151-7. PubMed ID: 17543292
[TBL] [Abstract][Full Text] [Related]
18. It is AMPA receptor, not kainate receptor, that contributes to the NBQX-induced antinociception in the spinal cord of rats.
Kong LL; Yu LC
Brain Res; 2006 Jul; 1100(1):73-7. PubMed ID: 16777075
[TBL] [Abstract][Full Text] [Related]
19. [Running fit and generalized tonic-clonic seizure are differently controlled by different subtype receptors in the brainstem].
Yasuda S; Ishida N; Higashiyama A; Kato N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):123-8. PubMed ID: 9866827
[TBL] [Abstract][Full Text] [Related]
20. Effects of an NMDA-receptor antagonist, MK-801, on central locomotor programming in the rabbit.
Fenaux F; Corio M; Palisses R; Viala D
Exp Brain Res; 1991; 86(2):393-401. PubMed ID: 1836763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
